Rebuilding the atrophied brain: Nasal esketamine 6-month therapy expands key frontal and hippocampal regions in patients with major depressive disorder

Neuroscience Applied 2026 Open access

Read full text
Authors: J.A. Garcia-Carmona, A. Rodriguez-Lorente, M.P. Campos Navarro, Á. Gil Montoya, C. Marin Pérez, M.L. Maso Navarro, M.D.C. Alcaraz Soto, T. Orgaz Morales, N. López Ramirez, J. Navarro-Zaragoza, P. Almela Rojo
DOI: 10.1016/j.nsa.2025.106797
Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Nicotinic Acetylcholine Receptors Study

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106797–106797
Publication date
1 January 2026
Language
EN